usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis
Go to homepage
€0.00*

Type in Search Term here to find products and any content
or filter the current selection by criteria below:

Filter
Filter and select current selecztion:

Peptides & Peptide Pools for Cancer Research

Discover our wide range of peptides and peptide pools, specifically designed for cancer research. Our offerings include cancer-testis antigens such as PRAME, MAGE, and NY-ESO-1, along with peptides and peptide pools from cancer-related viruses – and many more. We also welcome your suggestions for expanding our catalog, please feel free to email us. For unique peptide requests, our Custom Synthesis Service > is at your disposal.


Whether you are investigating cancer pathogenesis, creating diagnostic tools, or developing the next generation of immunotherapies, our extensive selection of peptides and peptide pools will support and enhance your research and development efforts.
AAV VP1 492-500 (HLA-A*01:01) ( SADNNNSEY )
#

From €60.40*
Details
ABI2 145-153 (HLA-A*02:01) ( ILDDIGHGV )
control peptide

From €60.40*
Details
ABL1 (HLA-A*02:01) ( CLWCVPQLR )
This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons.

From €60.40*
Details
Adpgk Neoepitope (H-2D(b)) ( ASMTNMELM )
#

From €60.40*
Details
Anti-H60a 39-46 (H-2Kb) ( LTFNYRNL )
The vector of anti-H60 peptide T cell receptor (TCR) is constructed for the engineering of T cell to target Mouse H60 peptide. The T cells are genetically modified through transduction with a retroviral vector expressing H60 peptide-specific T cell receptor.

From €60.40*
Details
Arg9 ( RRRRRRRRR )
This is a peptide comprising of 9 arginine residues. It has been shown that poly-Arg peptides composed of 9 arginine residues are able to efficiently translocate across cells. It has also been shown in model systems that Arg-9 translocation involves nucleation of transient pores enabling flow of ions across the membrane. and that it's electrostatic attraction to the phosphate groups of membranes is a key property for its translocation.

From €60.40*
Details
BA46 194-202 (HLA-A*02:01) ( NLFETPVEA )
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This peptide NLFETPVEA is covering 194-202 and is presenting MHC-Class I HLA- A*02:01.

From €60.40*
Details
BA46 97-106 (HLA-A*02:01) ( GLQHWVPEL )
This gene encodes a preproprotein that is proteolytically processed to form multiple protein products. The major encoded protein product, lactadherin, is a membrane glycoprotein that promotes phagocytosis of apoptotic cells. This protein has also been implicated in wound healing, autoimmune disease, and cancer. Lactadherin can be further processed to form a smaller cleavage product, medin, which comprises the major protein component of aortic medial amyloid (AMA). Alternative splicing results in multiple transcript variants.

From €60.40*
Details
BAP31 167-175 (HLA-A*02:01) ( KLDVGNAEV )
KLDVGNAEV is a linear peptidic epitope (epitope ID445492) studied as part of B-cell receptor-associated protein 31 from Homo sapiens (human). This epitope has been studied for immune reactivity and tested in MHC ligand assays

From €60.40*
Details
BCL-2 180-189 (HLA-A*02:01) ( YLNRHLHTWI )
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-2-derived peptide of YLNRHLHTWI sequence covering 180-189 and A*02:01 molecule.

From €60.40*
Details
BCL-2 208-217 (HLA-A*02:01) ( PLFDFSWLSL )
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-2-derived peptide of PLFDFSWLSL sequence covering 208-217 and A*02:01 molecule.

From €60.40*
Details
Bcl-2 214-223 (HLA-A*02:01) ( WLSLKTLLSL )
Bcl-2 peptide WLSLKTLLSL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell lymphoma 2 (Bcl-2) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.

From €60.40*
Details
BCL-2 85-93 (HLA-A*02:01) ( ALSPVPPVV )
#

From €60.40*
Details
BCL-2A1 15-23 (HLA-A*24:02) ( DYLQYVLQI )
This peptides are used for the detection of antigen-specific T-cell populations. MHC-peptide tetramer complexes recognize antigen specific T-cells at the single cell level, allowing for accurate measurements of the functional immune response in cancer, infectious diseases, and autoimmune diseases.ï¾  Due to their increased avidity, MHC tetramers stably bind to cognate TcRs and are evaluated using flow cytometry.

From €60.40*
Details
BCL-2L1 165-173 (HLA-A*03:01) ( RIAAWMATY )
#

From €60.40*
Details
BCL2-like 1 173-182 (HLA-A*02:01) ( YLNDHLEPWI )
This peptides has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed BCL-X-derived peptide of YLNDHLEPWI sequence covering 173-182 and A*02:01 molecule.

From €60.40*
Details
BCR-ABL (HLA-A*02:01) ( GVRGRVEEI )
#

From €60.40*
Details
BCR-ABL 19-27 (HLA-B*27:01) ( GFKQSSKAL )
Tumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assayTumor Antigen-derived Peptide. GFKQSSKAL is a linear peptidic epitope (epitope ID19558) studied as part of Other Homo sapiens (human) protein from Homo sapiens (human), tested in MHC ligand assay

From €60.40*
Details
BCR-ABL 926-934 (HLA-A*02:01) ( SSKALQRPV )
#

From €60.40*
Details
BCR/ABL 210 kD fusion protein 21-29 (HLA-A*03:01) ( KQSSKALQR )

From €60.40*
Details
BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01) ( ATGFKQSSK )
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.

From €60.40*
Details
BGLAP (HLA-A*24:02) ( LYQWLGAPV )
#

From €60.40*
Details
BGLAP 1-10 (HLA-A*02:01) ( YLYQWLGAPV )
#

From €60.40*
Details
BKV Large T antigen 579-587 (HLA-A*02:01) ( LLLIWFRPV )
BKV LT-ag peptide LLLIWFRPV (HLA-A*02:01) for stimulation of human BKV LT-ag(579-587)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. LLLIWFRPV is a linear peptidic epitope (epitope ID37507) studied as part of Human polyomavirus 1 (polyomavirus BK) protein from Human polyomavirus 1 (BK polyomavirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay.

From €60.40*
Details
usps-logo.jpg?1721728722
Ultrafast Ultrasonic Synthesis
Catalog peptides: immediate delivery
ISO 9001/2015 certified
1000 peptides & peptide pools
30 years of experience in peptide synthesis
This website uses cookies to ensure the best experience possible. More information...